Dwan‐Ying Chang

546 total citations
38 papers, 374 citations indexed

About

Dwan‐Ying Chang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Dwan‐Ying Chang has authored 38 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Dwan‐Ying Chang's work include Advanced Breast Cancer Therapies (11 papers), HER2/EGFR in Cancer Research (7 papers) and Cancer Treatment and Pharmacology (7 papers). Dwan‐Ying Chang is often cited by papers focused on Advanced Breast Cancer Therapies (11 papers), HER2/EGFR in Cancer Research (7 papers) and Cancer Treatment and Pharmacology (7 papers). Dwan‐Ying Chang collaborates with scholars based in Taiwan, United States and Japan. Dwan‐Ying Chang's co-authors include Yen‐Shen Lu, Weili Ma, Shu‐Chien Huang, Ann‐Lii Cheng, Ching‐Hung Lin, Ruey‐Jien Chen, Chiun‐Sheng Huang, Wen‐Hung Kuo, Pau‐Chung Chen and Mingyang Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Dwan‐Ying Chang

37 papers receiving 368 citations

Peers

Countries citing papers authored by Dwan‐Ying Chang

Since Specialization

Citations

This map shows the geographic impact of Dwan‐Ying Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dwan‐Ying Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dwan‐Ying Chang more than expected).

Fields of papers citing papers by Dwan‐Ying Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dwan‐Ying Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dwan‐Ying Chang. The network helps show where Dwan‐Ying Chang may publish in the future.

Co-authorship network of co-authors of Dwan‐Ying Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Dwan‐Ying Chang. A scholar is included among the top collaborators of Dwan‐Ying Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dwan‐Ying Chang. Dwan‐Ying Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Benefit of adjuvant chemotherapy for T1cN0M0 and selected T1bN0M0 triple-negative breast cancer: a nationwide cancer registry-based study 2025 ·The Oncologist ·Chiao Lo, Dwan‐Ying Chang, Yen‐Shen Lu, Ming‐Yang Wang, (unknown), Chiun‐Sheng Huang, (unknown), Ching‐Hung Lin	1
2	Hormone therapy enhances anti-PD1 efficacy in premenopausal estrogen receptor-positive and HER2-negative advanced breast cancer 2024 ·Cell Reports Medicine ·I‐Chun Chen, Ching‐Hung Lin, Dwan‐Ying Chang, Tom Wei‐Wu Chen, Mingyang Wang, Weili Ma, (unknown), Shu‐Min Huang, Chia‐Lang Hsu, Yen‐Shen Lu	3
3	Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐positive early breast cancer: A meta‐regression analysis 2024 ·Cancer Medicine ·Minghan Yang, Chiun‐Sheng Huang, Dwan‐Ying Chang, Fu‐Chang Hu, Shu‐Min Huang, (unknown), I‐Chun Chen, Tom Wei‐Wu Chen, Ching‐Hung Lin, Yen‐Shen Lu	2
4	Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer 2023 ·Breast Cancer Research and Treatment ·Tom Wei‐Wu Chen, (unknown), Ming‐Shen Dai, Ching‐Hung Lin, Dwan‐Ying Chang, I‐Chun Chen, Mingyang Wang, (unknown), Shu‐Min Huang, Ann‐Lii Cheng, (unknown), Kien Thiam Tan, Yen‐Shen Lu	5
5	Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis 2023 ·Cancer Medicine ·(unknown), Ching‐Hung Lin, I‐Chun Chen, Ying‐Chun Shen, Dwan‐Ying Chang, Tom Wei‐Wu Chen, Shu‐Min Huang, Fu‐Chang Hu, Yen‐Shen Lu	1
6	Abstract CT141: Combination of hormone therapy, GnRH agonist, and immunotherapy enhance immune activation in premenopausal ER+/HER2- metastatic breast cancer patients: Results of biomarker analysis from a pilot phase II study 2023 ·Cancer Research ·I‐Chun Chen, Ching‐Hung Lin, Dwan‐Ying Chang, Tom Wei‐Wu Chen, Mingyang Wang, Weili Ma, Yi-Ting Lin, Shu‐Min Huang, Yen‐Shen Lu	3
7	Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices 2022 ·The Oncologist ·Weili Ma, Dwan‐Ying Chang, Ching‐Hung Lin, Kao‐Lang Liu, Po‐Chin Liang, Huang‐Chun Lien, (unknown), Lingyun Huang, Yi‐Chun Yeh, Yen‐Shen Lu	2
8	Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives 2021 ·Therapeutics and Clinical Risk Management ·Dwan‐Ying Chang, Weili Ma, Yen‐Shen Lu	59
9	A case-control study of perfluoroalkyl substances and the risk of breast cancer in Taiwanese women 2020 ·Environment International ·Meng‐Shan Tsai, (unknown), Wen‐Hung Kuo, Ching‐Hua Kuo, (unknown), Mingyang Wang, Dwan‐Ying Chang, Yen‐Shen Lu, Chiun‐Sheng Huang, Ann‐Lii Cheng, Ching‐Hung Lin, Pau‐Chung Chen	76
10	A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer 2017 ·Japanese Journal of Clinical Oncology ·Tom Wei‐Wu Chen, Dah‐Cherng Yeh, Tsu‐Yi Chao, Ching‐Hung Lin, (unknown), Dwan‐Ying Chang, (unknown), Shu‐Min Huang, Ann‐Lii Cheng, Yen‐Shen Lu	2
11	Acute Hyponatremia Complicated with Seizure after Adjuvant Chemotherapy with Cyclophosphamide and Epirubicin in a Breast Cancer Patient 2015 ·SHILAP Revista de lepidopterología ·(unknown), Dwan‐Ying Chang	1
12	High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country 2015 ·PLoS ONE ·Ching‐Hung Lin, Chen‐Yang Shen, Jih‐Hsiang Lee, Chiun‐Sheng Huang, James Chih‐Hsin Yang, Wen‐Hung Kuo, Dwan‐Ying Chang, Chia‐Ni Hsiung, Kuan‐Ting Kuo, Tom Wei‐Wu Chen, I‐Chun Chen, Pei‐Fang Wu, Sung‐Hsin Kuo, Chien‐Jen Chen, Yen‐Shen Lu, Ann‐Lii Cheng	9
13	TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays 2015 ·Scientific Reports ·Ching‐Hung Lin, (unknown), Chiun‐Sheng Huang, Fu‐Chang Hu, Wen‐Hung Kuo, Kuan‐Ting Kuo, Chung‐Chieh Wang, Pei‐Fang Wu, Dwan‐Ying Chang, Mingyang Wang, (unknown), Tom Wei‐Wu Chen, Yen‐Shen Lu, Ann‐Lii Cheng	10
14	Malignant Pleural Mesothelioma with Extensive Skeletal Muscle Metastasis 2014 ·SHILAP Revista de lepidopterología ·Chia‐Chun Chiang, (unknown), Dwan‐Ying Chang	1
15	The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines 2013 ·The Breast ·Tom Wei‐Wu Chen, Dwan‐Ying Chang, Shu‐Min Huang, Ching‐Hung Lin, (unknown), (unknown), Chiun‐Sheng Huang, Yen‐Shen Lu, Ann‐Lii Cheng	5
16	Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation 2012 ·Journal of Clinical Pathology ·Ching‐Hung Lin, (unknown), Yen‐Shen Lu, Chieh Lan, Wei-Chung Allen Lee, Kuan‐Ting Kuo, Chung‐Chieh Wang, Dwan‐Ying Chang, Chiun‐Sheng Huang, Ann‐Lii Cheng	13
17	Minimizing bladder injury in laparoscopically assisted vaginal hysterectomy among women with previous cesarean sections 2007 ·Surgical Endoscopy ·(unknown), Wen-Wei Hsu, Bor‐Ching Sheu, Shu‐Chien Huang, Pao‐Ling Torng, Dwan‐Ying Chang	14
18	Prevalence of single and multiple infection with human papillomaviruses in various grades of cervical neoplasia 1997 ·Journal of Medical Microbiology ·Dwan‐Ying Chang, Ruey‐Jien Chen, (unknown), Shu‐Chien Huang	28
19	Comparison of detection of human papillomavirus 16 DNA in cervical carcinoma tissues by Southern blot hybridisation and nested polymerase chain reaction 1995 ·Journal of Medical Microbiology ·Dwan‐Ying Chang, (unknown), Ruey‐Jien Chen, (unknown), Shu‐Chien Huang	11
20	Adenomatoid tumor of the female genital tract 1995 ·International Journal of Gynecology & Obstetrics ·C.-C. Huang, Dwan‐Ying Chang, (unknown), (unknown), Shu‐Chien Huang	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact